Detalhe da pesquisa
1.
Overall haemostatic potential (OHP) assay can risk stratify for venous thromboembolism recurrence in anticoagulated patients.
J Thromb Thrombolysis
; 55(1): 32-41, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-35908244
2.
Risk factors and early prediction of clinical deterioration and mortality in adult COVID-19 inpatients: an Australian tertiary hospital experience.
Intern Med J
; 52(4): 550-558, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34806276
3.
Real-world direct oral anticoagulant experience in atrial fibrillation: falls risk and low dose anticoagulation are predictive of both bleeding and stroke risk.
Intern Med J
; 50(11): 1359-1366, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31566857
4.
The Need for Individualized Risk Assessment in Cardiovascular Disease.
J Pers Med
; 12(7)2022 Jul 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35887637
5.
Deferasirox-induced liver injury and Fanconi syndrome in a beta-thalassemia major male.
BMJ Case Rep
; 13(7)2020 Jul 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32646935
6.
The evaluation of overall hemostatic potential assay in patients with COVID-19 infection.
Int J Lab Hematol
; 44(5): e219-e223, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35622058
7.
Hyperleukocytosis associated with delayed presentation among patients with acute leukemia during the COVID-19 pandemic.
Leuk Lymphoma
; 63(11): 2731-2734, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35727162
8.
Global coagulation assays in patients with multiple myeloma and monoclonal gammopathy of unknown significance.
Thromb Res
; 183: 45-48, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31669660